SCHEMBL28375786

SCHEMBL28375786

CC(C)N(N)C(=O)c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.53
F3 P13726 1/20 0.53
SARM1 Q6SZW1 1/20 0.53
SIRT2 Q8IXJ6 1/20 0.53
SIRT6 Q8N6T7 1/20 0.53
SIRT1 Q96EB6 1/20 0.53
SIRT3 Q9NTG7 1/20 0.53
SIRT5 Q9NXA8 1/20 0.53
SIRT4 Q9Y6E7 1/20 0.53
ALDH1A1 P00352 3/20 0.50
GAA P10253 2/20 0.50
TP53 P04637 2/20 0.50
TSHR P16473 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HTT P42858 1/20 0.50
APP P05067 1/20 0.50
HCAR3 P49019 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591435 0.83 TP53 (0.56) F7F3SARM1SIRT2SIRT6
Hydrochloric Acid SCHEMBL28042957 0.81 TP53 (0.55) F7F3SARM1SIRT2SIRT6
SCHEMBL6029641 0.81 HSD17B10 (0.55) F7F3SARM1SIRT2SIRT6
SCHEMBL4002015 0.81 F7 (0.58) F7F3SARM1SIRT2SIRT6
SCHEMBL6227030 0.80 F7 (0.62) F7F3SARM1SIRT2SIRT6
SCHEMBL4000774 0.79 KDM4E (0.47) ALDH1A1TP53TSHRHSD17B10HTT
SCHEMBL4667859 0.78 TRPM8 (0.47) ALDH1A1TP53TSHRHSD17B10NPSR1
SCHEMBL14857135 0.78 HTT (0.62) F7F3SARM1SIRT2SIRT6
SCHEMBL6030378 0.78 HTT (0.58) F7F3SARM1SIRT2SIRT6
SCHEMBL161322 0.77 ALDH1A1 (0.59) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655247-A Enhancing T cell function and treating T cell dysfunction disorders with a combination of a LSD inhibitor and a PD1 binding antagonist 艾比克斯治疗私人有限公司 2020-09-11 CN claimed
CN-111655247-A Enhancing T cell function and treating T cell dysfunction disorders with a combination of a LSD inhibitor and a PD1 binding antagonist 艾比克斯治疗私人有限公司 2020-09-11 CN disclosed
CN-110770221-A Methods for improving memory and cognition and for treating memory and cognitive disorders 卡维昂公司 2020-02-07 CN disclosed